Prevalence of human papillomavirus among women with normal cervical cytology in Kuwait
Affiliations
Affiliations
- Department of Medical Laboratory Sciences, Faculty of Allied Health Sciences, Kuwait University, Kuwait. r.al-awadhi@hsc.edu.kw
Abstract
This study was undertaken to determine the prevalence and type specific distribution of human papillomavirus (HPV) in women with normal cervical cytology in Kuwait. The study is the first of its type in Kuwait and one of few in the Middle East. The age specific distribution of HPV types was determined in 3,011 ThinPrep samples taken from women seeking routine gynaecological care. ThinPrep samples were screened for HPV DNA by real-time PCR. The type specific distribution of the viruses was determined by PCR-based sequencing. The results showed that HPV DNA was detected in 71 women (2.4%), and 21 different HPV genotypes were detected, comprising eight high-risk (HR) (16, 31, 33, 53, 56, 58, 66, and 73), seven low-risk (LR) (6, 11, 54, 61, 70, 81, and 90), four intermediate-risk (IR) (67, 82, 83, and 84) and HPV 102 and HPV 106. LR HPV types were found in 71.8% of infected samples, HR types in 32.3%, and IR types in 7%. With regard to age, 40.8% of all HPVs were found in women 30-39 years of age, 29.6% in women 40-49 years of age, 19.7% in women over 50 years and 9.9% in women less than 34 years old. The study shows that the prevalence of HPV infection in Kuwait is among the lowest in the world and suggests that HPV vaccine could prevent the development of HPV associated cervical cancer in 1.39% of young females living in Kuwait. However, more extensive population-based studies should be undertaken before implementing HPV vaccination.
Similar articles
Distribution of human papillomavirus among women with abnormal cervical cytology in Kuwait.
Al-Awadhi R, Chehadeh W, Jaragh M, Al-Shaheen A, Sharma P, Kapila K.Diagn Cytopathol. 2013 Feb;41(2):107-14. doi: 10.1002/dc.21778. Epub 2011 Oct 11.PMID: 21987449
Agarossi A, Ferrazzi E, Parazzini F, Perno CF, Ghisoni L.J Med Virol. 2009 Mar;81(3):529-35. doi: 10.1002/jmv.21347.PMID: 19152401
Kovács K, Varnai AD, Bollmann M, Bankfalvi A, Szendy M, Speich N, Schmitt C, Pajor L, Bollmann R.J Med Virol. 2008 Oct;80(10):1814-23. doi: 10.1002/jmv.21282.PMID: 18712836
Kovachev S, Nacheva A.Akush Ginekol (Sofiia). 2010;49(4):25-31.PMID: 20734638 Bulgarian.
Peng RR, Li HM, Chang H, Li JH, Wang AL, Chen XS.Sex Health. 2012 May;9(2):113-9. doi: 10.1071/SH11066.PMID: 22498154 Free PMC article. Review.
Cited by
Alsanafi M, Salim NA, Sallam M.Hum Vaccin Immunother. 2023 Dec 31;19(1):2194772. doi: 10.1080/21645515.2023.2194772. Epub 2023 Apr 2.PMID: 37005342 Free PMC article.
Barriers to the HPV vaccination program in the Eastern Mediterranean region: a narrative review.
Hakimi S, Lami F, Allahqoli L, Alkatout I.J Turk Ger Gynecol Assoc. 2023 Mar 15;24(1):48-56. doi: 10.4274/jtgga.galenos.2022.2022-6-6. Epub 2022 Dec 30.PMID: 36583290 Free PMC article.
Fernandes Q, Allouch S, Gupta I, Elmakaty I, Elzawawi KE, Amarah A, Al-Thawadi H, Al-Farsi H, Vranic S, Al Moustafa AE.Pathogens. 2022 Nov 19;11(11):1380. doi: 10.3390/pathogens11111380.PMID: 36422631 Free PMC article. Review.
Evidence-based circumcision policy for Australia.
Morris BJ, Katelaris A, Blumenthal NJ, Hajoona M, Sheen AC, Schrieber L, Lumbers ER, Wodak AD, Katelaris P.J Mens Health. 2022;18(6):132. doi: 10.31083/j.jomh1806132. Epub 2022 May 30.PMID: 36034719 Free PMC article.
High risk human papilloma virus (HPV) common among a cohort of women with female genital mutilation.
Ogah J, Kolawole O, Awelimobor D.Afr Health Sci. 2019 Dec;19(4):2985-2992. doi: 10.4314/ahs.v19i4.19.PMID: 32127873 Free PMC article.